TELA Bio to Participate in Upcoming Needham & Co. 21st Annual Healthcare Virtual Conference

Rhea-AI Summary

TELA Bio, a medical technology company, announced its participation in the Needham & Co. 21st Annual Healthcare Virtual Conference on April 12, 2022, at 2:15 PM ET. TELA Bio focuses on soft-tissue reconstruction solutions that prioritize preserving the patient's anatomy. Management will present at the conference, and interested parties can access the live and archived webcast via their investor relations website. TELA Bio is committed to providing advanced technologies that enhance clinical outcomes while reducing reliance on permanent synthetic materials.

MALVERN, Pa., March 30, 2022 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy, today announced that the Company will participate in the Needham & Co. 21st Annual Healthcare Virtual Conference on April 12^th, 2022.

TELA Bio’s management is scheduled to present at the Needham & Co. 21st Annual Healthcare Virtual Conference on April 12^th, 2022, at 2:15pm ET. Interested parties can access the live and archived webcast at ir.telabio.com.

About TELA Bio, Inc.

TELA Bio, Inc. (NASDAQ: TELA) is a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy. The Company is committed to providing surgeons with advanced, economically effective soft-tissue reconstruction solutions that leverage the patient’s natural healing response while minimizing long-term exposure to permanent synthetic materials. For more information, visit www.telabio.com.

Investor Contact
Greg Chodaczek
332-895-3230
ir@telabio.com

FAQ

When is TELA's presentation at the Needham & Co. Healthcare Virtual Conference?

TELA Bio's presentation is scheduled for April 12, 2022, at 2:15 PM ET.

How can I access TELA's presentation from the conference?

You can access TELA's live and archived presentation on their investor relations website.

What does TELA Bio focus on in their medical technology solutions?

TELA Bio focuses on innovative soft-tissue reconstruction solutions that prioritize the preservation of the patient's anatomy.

What is TELA's stock symbol?

TELA Bio's stock symbol is TELA.

What is the purpose of TELA Bio's participation in the conference?

The purpose of TELA's participation is to present their innovative technologies and discuss clinical outcomes.